Twin City Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
43,109
-453
-1% -$12.1K 0.92% 43
2025
Q4
$1.08M Sell
43,562
-2,199
-5% -$55.5K 0.82% 44
2025
Q3
$1.17M Buy
45,761
+1,252
+3% +$30.9K 0.91% 42
2025
Q2
$1.08M Buy
44,509
+1,769
+4% +$41.3K 0.88% 48
2025
Q1
$1.08M Buy
42,740
+2,608
+6% +$68.2K 0.95% 40
2024
Q4
$1.06M Sell
40,132
-5,160
-11% -$140K 0.94% 43
2024
Q3
$1.31M Sell
45,292
-705
-2% -$20.6K 1.14% 39
2024
Q2
$1.29M Sell
45,997
-1,407
-3% -$38.7K 1.22% 37
2024
Q1
$1.32M Buy
+47,404
New +$1.32M 1.3% 35

Other funds holding PFE

Twin City Private Wealth's PFE Position: Q1 2026 in Review

Twin City Private Wealth reduced its Pfizer (PFE) stake by 1% in Q1 2026, selling an estimated $12.1K and leaving 43,109 shares worth $1.21M. The position accounts for 0.92% of the portfolio, ranked #43.

Twin City Private Wealth first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.32M in Q1 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Twin City Private Wealth held 43,109 shares of Pfizer worth $1.21M as of Q1 2026.
  • Twin City Private Wealth sold 453 Pfizer shares in Q1 2026, an estimated $12.1K.
  • Pfizer made up 0.92% of Twin City Private Wealth's portfolio in Q1 2026, its #43 holding.
  • Twin City Private Wealth first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • Twin City Private Wealth's Pfizer position peaked at $1.32M in Q1 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Twin City Private Wealth's 13F filing for Q1 2026, filed 24 Apr 2026.